Health food of bacillus natto fermented fluid milk and production method thereof

Abstract

The invention relates to foods, in particular to a health food of bacillus natto fermented fluid milk and a production method thereof. The health food is a natto kinase dairy product obtained from bacillus natto fermentation fluid milk, for every 100 weight parts of fluid milk, 10 or less than 10 weight parts of edible grade glycerin and 10 or less than 10 weight parts of a sweetening agent are added, and the natto kinase activity of 100ml end product is higher than 3000 IU. The health food which is cheap and at the same time very good is provided for patients with coronary heart disease, brain infarction, arteriosclerosis, hypertension, hyperlipidemia, hyperglycemia, high blood viscosity, hyperuricemia and gout, as well as general population. The health food has the advantages that raw materials are easy to access, the formulation is simple, the fermentation time is short, the taste is sweet, cane sugar is not contained, the content of purine is low, and edible safety and convenience are achieved. A user not only can absorb nutrient content in milk or goat milk, but also can absorb nattokinase having multiple health-caring functions, and the health food has a popularization and promotion value. According to the invention, a novel fermented milk field and consumer groups thereof are widened for dairy industry.

Description

technical field [0001] The invention relates to a food, in particular a health food made of milk fermented by Bacillus natto and a preparation method thereof. Background technique [0002] Cardiovascular and cerebrovascular embolism diseases, such as coronary heart disease, myocardial infarction, cerebral infarction, etc., are one of the main causes of death in middle-aged and elderly people. According to the World Health Organization (WHO) estimates, the number of people who die of cardiovascular and cerebrovascular diseases worldwide More than 15 million people, second only to cancer. There are more than 180 million people over the age of 60 in my country, and we have entered an aging society. The prevention and treatment of cardiovascular and cerebrovascular diseases must attract sufficient attention. Vascular thrombotic disease is a high incidence of middle-aged and elderly people, and it is one of the diseases with the greatest risk of death. Currently, thrombolytic dr...

AI Technical Summary

Problems solved by technology

Vascular thrombotic disease is a high incidence of middle-aged and elderly people, and it is one of the diseases with the greatest risk of death. Currently, thrombolytic drugs such as streptokinase, urokinase, and tissue plasminogen activator exist in the domestic market. Several disadvantages: short duration of action, hemorrhagic side effects, oral ineffectiveness, expensive

Nattokinase is a heat-sensitive protease, which is easily denatured and inactivated when heated above 60°C, resulting in a reduction or even disappearance of its thrombolytic activity. Therefore, in the production of commercial nattokinase, it is desirable to retain a higher The thrombolytic activity of nattokinase and the high concentration of the product have put forward high requirements for the production process. For example, the method of obtaining a dry product by filtration and purification and freeze-drying has high production costs, long production cycles, and high commodity prices.

[0005] Natto and nattokinase products fermented from soybeans have the following disadvantages: 1. High purine content, which is taboo for patients with increased uric acid and gout; 2. The isoflavone contained in natto is a kind of phytoestrogens, suitable Taking it by women can inhibit the sexual function of men; 3. Natto or nattokinase has a unique odor, which is difficult for people who have no eating habits, especially women

So far, no sucrose-free, low-purine, no-odor milk products fermented with Bacillus natto and nattokinase have not been publicly sold

Images